https://www.selleckchem.com/pr....oducts/Staurosporine
2% versus 21% (P=0.00-and had a shorter length of stay (5 vs. 7 d; P=0.018). Overall survival was similar between the NACT and PDS groups (58.7 vs. 59.7 mo; LR -0.836; P=0.361) despite lower progression-free survival in the NACT group (25.9 vs. 47.1 mo; P=0.042; LR 4.31). Both progression-free and overall survival were significantly higher when patients undergoing NACT achieved complete debulking (21.7 and 102.3 mo, respectively) compared with suboptimal debulking (12.03 and 14.2 mo, respectively). In this select group older pat